Development and validation of a clinical scale for rating the severity of Blepharospasm-Reference-Cited by-同舟云学术

Development and validation of a clinical scale for rating the severity of Blepharospasm

Published:2015-04 Issue:4 Volume:30 Page:525-530
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Defazio Giovanni¹,Hallett Mark²,Jinnah Hyder A.³,Stebbins Glenn T.⁴,Gigante Angelo F.¹,Ferrazzano Gina⁵,Conte Antonella⁵⁶,Fabbrini Giovanni⁵⁶,Berardelli Alfredo⁵⁶

Affiliation:

1. Department of Basic Medical Sciences, Neuroscience and Sensory Organs; “Aldo Moro” University of Bari; Bari Italy

2. Human Motor Control Section; NINDS, NIH; Bethesda Maryland USA

3. Department of Neurology; Emory University; Atlanta Georgia USA

4. Department of Neurological Sciences; Rush University Medical Center; Chicago Illinois USA

5. Department of Neurology and Psychiatry; Sapienza University of Rome; Rome Italy

6. IRCCS INM Neuromed; Pozzilli (IS) Italy

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mds.26156/fullpdf

Reference18 articles.

1. The prevalence of primary dystonia: a systematic review and meta-analysis;Steeves;Mov Disord.,2012

2. Blepharospasm: a review of 264 patients;Grandas;J Neurol Neurosurg Psychiatry,1988

3. Update on blepharospasm: report from the BEBRF International Workshop;Hallett;Neurology,2008

4. The focal dystonias: current views and challenges for future research;Jinnah;Mov Disord,2013

5. Do primary adult-onset focal dystonias share aetiological factors?;Defazio;Brain,2007

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of 0.3% Hyaluronic Acid Eye Drops for Benign Essential Blepharospasm and Hemifacial Spasm with Botulinum Toxin–induced Dry Eye;Plastic and Reconstructive Surgery - Global Open;2024-08

2. Traducción, adaptación y validación transcultural de la escala CDQ-24 en pacientes con blefaroespasmo primario en tratamiento con toxina botulínica, prueba piloto;Archivos de la Sociedad Española de Oftalmología;2024-08

3. Translation, adaptation, and cross-cultural validation of the CDQ-24 scale in patients with primary blepharospasm under botulinum toxin treatment, pilot test;Archivos de la Sociedad Española de Oftalmología (English Edition);2024-08

4. Longitudinal assessment of blepharospasm severity in patients with long disease duration;Parkinsonism & Related Disorders;2024-06

5. Reliability and usability of telemedicine evaluations for facial dystonia;iScience;2024-06